ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 91 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $306,000 | +45.7% | 33,200 | +22.1% | 0.00% | – |
| Q4 2016 | $210,000 | -32.5% | 27,200 | 0.0% | 0.00% | – |
| Q3 2016 | $311,000 | +77.7% | 27,200 | +91.5% | 0.00% | – |
| Q2 2016 | $175,000 | +26.8% | 14,200 | 0.0% | 0.00% | – |
| Q1 2016 | $138,000 | -44.4% | 14,200 | +29.1% | 0.00% | -100.0% |
| Q4 2015 | $248,000 | +36.3% | 11,000 | 0.0% | 0.00% | – |
| Q3 2015 | $182,000 | -12.1% | 11,000 | +19.6% | 0.00% | -100.0% |
| Q2 2015 | $207,000 | +7.3% | 9,200 | +22.7% | 0.00% | 0.0% |
| Q1 2015 | $193,000 | +18.4% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $163,000 | +14.8% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $142,000 | -18.9% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $175,000 | – | 7,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,042,989 | $8,571,000 | 0.75% |
| NEXTHERA CAPITAL LP | 634,715 | $1,346,000 | 0.26% |
| Endurant Capital Management LP | 219,114 | $465,000 | 0.21% |
| Birchview Capital, LP | 118,689 | $252,000 | 0.16% |
| Perceptive Advisors | 2,620,897 | $5,556,000 | 0.15% |
| Alambic Investment Management, L.P. | 53,972 | $114,000 | 0.09% |
| Sofinnova Investments, Inc. | 395,744 | $839,000 | 0.08% |
| Kazazian Asset Management, LLC | 31,475 | $67,000 | 0.06% |
| Broadfin Capital, LLC | 200,000 | $424,000 | 0.06% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 96,639 | $205,000 | 0.02% |